LMAT · Lemaitre Vascular Inc
$81.86
-0.46 (-0.56%)
At close · Aug 21
Market Cap
$1.87B
Shares
22.87M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$249.6M
+13.5%
FY2025
Net Income
$57.73M
+31.1%
FY2025
Gross Margin
71.53%
+2.9pp
FY2025
Operating Margin
27.21%
+3.4pp
FY2025
Diluted EPS
$2.52
+30.6%
FY2025
Operating Cash Flow
$81.25M
+84.1%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2026 (G) | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $274.3M – $278.3M | $262.43M | $249.6MG | $219.86M | $193.48M | $161.65M | $154.42M | $129.37M | $117.23M | $105.57M | $100.87M | $89.15M | $78.35M | $71.1M | $64.55M | $56.74M | $57.69M | $56.06M | $50.91M | |
| — | $71.13M | $71.06M | $68.96M | $66.44M | $56.76M | $53.04M | $44.75M | $37.38M | $31.63M | $30.17M | $26.22M | $24.19M | $22.67M | $19.43M | $15.87M | $17.46M | $14.34M | $13.6M | |
| — | $191.31M | $178.54M | $150.9M | $127.05M | $104.9M | $101.38M | $84.62M | $79.85M | $73.94M | $70.7M | $62.94M | $54.17M | $48.43M | $45.12M | $40.87M | $40.23M | $41.72M | $37.3M | |
| — | — | 71.53% | 68.63% | 65.66% | 64.89% | 65.65% | 65.41% | 68.12% | 70.04% | 70.09% | 70.59% | 69.13% | 68.12% | 69.89% | 72.03% | 69.74% | 74.42% | 73.28% | |
| — | $15.41M | $14.14M | $15.65M | $16.97M | $13.29M | $11.8M | $10.1M | $9.28M | $8.2M | $6.64M | $6.14M | $5.48M | $4.67M | $5.24M | $5.09M | $4.43M | $5.49M | $5.91M | |
| — | $54.28M | $54.46M | $46.74M | $41.05M | $32.92M | $27.66M | $23.7M | $30.34M | $27.32M | $25.95M | $26.11M | $22.78M | $22.09M | $22.14M | $20.81M | $19.38M | $19.41M | $17.71M | |
| — | $44.3M | $42.02M | $36.26M | $31.83M | $28.75M | $25.5M | $22.5M | $19.06M | $17.69M | $17.01M | $14.35M | $14.01M | $13.89M | $12.58M | $10.97M | $11.23M | $10.51M | $9.85M | |
| — | $5.62M | $5.64M | $5.79M | $6.09M | $6.18M | $6.2M | $5.04M | $2.44M | $1.76M | $1.79M | $1.61M | $1.51M | $1.54M | $1.22M | $915K | $990K | $683K | — | |
| — | — | $10.42M | $9.61M | $9.52M | $9.43M | $11.07M | $8.4M | $5.42M | $4.32M | $4.06M | $3.59M | $3.39M | $3.33M | $2.79M | $2.23M | $2.04M | $1.38M | $1.42M | |
| — | — | — | — | — | $3.1M | — | — | — | — | — | — | — | $526K | — | — | $2.16M | $1.82M | $1.78M | |
| — | $113.99M | $110.63M | $98.65M | $90.34M | $78.07M | $64.96M | $55.83M | $58.67M | $45.73M | $49.59M | $46.6M | $42.65M | $42.09M | $40.6M | $36.63M | $36.54M | $37.7M | $35.36M | |
| — | $77.32M | $67.91M | $52.26M | $36.71M | $26.83M | $36.43M | $28.79M | $21.18M | $28.21M | $21.1M | $16.34M | $11.51M | $6.34M | $4.52M | $4.24M | $3.69M | $4.02M | $1.95M | |
| — | — | 27.21% | 23.77% | 18.97% | 16.6% | 23.59% | 22.25% | 18.07% | 26.72% | 20.92% | 18.32% | 14.69% | 8.92% | 7% | 7.47% | 6.4% | 7.16% | 3.83% | |
| — | — | $78.33M | $61.86M | $46.23M | $36.26M | $47.5M | $37.18M | $26.6M | $32.53M | $25.16M | $19.93M | $14.91M | $9.67M | $7.31M | $6.47M | $5.73M | $5.39M | $3.37M | |
| — | $5.2M | $5.18M | $205K | $0 | $0 | $2.22M | $1.31M | $0 | $2000 | $21K | $14K | — | $5000 | $12K | $1000 | — | $5000 | $26K | |
| — | $13.92M | $13.09M | $4.95M | $3.08M | $986K | $197K | $207K | $698K | $631K | $179K | $81K | $13K | $1000 | $4000 | $78K | $11K | $31K | $38K | |
| — | -$1.31M | -$638K | -$125K | -$314K | -$325K | -$116K | -$329K | — | — | — | — | — | — | — | $5000 | — | $14K | -$26K | |
| — | $84.73M | $75.18M | $56.88M | $39.48M | $27.49M | $34.29M | $27.36M | $21.68M | $28.44M | $21.11M | $16.24M | $11.42M | $6.32M | $4.33M | $3.99M | $3.75M | $4.03M | $2.22M | |
| — | $19.06M | $17.45M | $12.84M | $9.37M | $6.85M | $7.38M | $6.14M | $3.75M | $5.5M | $3.93M | $5.65M | $3.67M | $2.41M | $1.13M | $1.42M | $1.61M | -$1.99M | $617K | |
| — | $65.67M | $57.73M | $44.04M | $30.11M | $20.64M | $26.91M | $21.22M | $17.93M | $22.94M | $17.18M | $10.59M | $7.76M | $3.92M | $3.2M | $2.57M | $2.14M | $6.01M | $1.6M | |
| — | — | 23.13% | 20.03% | 15.56% | 12.77% | 17.42% | 16.4% | 15.3% | 21.73% | 17.03% | 11.88% | 9.9% | 5.51% | 4.96% | 4.53% | 3.72% | 10.73% | 3.14% | |
| — | $64.51M | $61.51M | $42.48M | $31.51M | $18.04M | $25M | $23.7M | $17.83M | $21.33M | $19.47M | $10.06M | $6.07M | $1.8M | $3.38M | $2.74M | $1.97M | $5.49M | — | |
| USD/shares | — | — | $2.55 | $1.96 | $1.36 | $0.94 | $1.27 | $1.05 | $0.91 | $1.18 | $0.91 | $0.57 | $0.44 | $0.24 | $0.21 | $0.17 | $0.14 | $0.38 | $0.10 |
| USD/shares | — | — | $2.52G | $1.93 | $1.34 | $0.93 | $1.25 | $1.04 | $0.88 | $1.13 | $0.86 | $0.55 | $0.42 | $0.23 | $0.20 | $0.16 | $0.13 | $0.37 | $0.10 |
| shares | — | — | 22.64M | 22.45M | 22.22M | 21.98M | 21.16M | 20.25M | 19.81M | 19.43M | 18.96M | 18.49M | 17.76M | 16.61M | 15.32M | 15.19M | 15.46M | 15.63M | 15.69M |
| shares | — | — | 22.93M | 22.78M | 22.42M | 22.17M | 21.48M | 20.48M | 20.33M | 20.24M | 20.03M | 19.24M | 18.32M | 17.01M | 15.76M | 15.64M | 15.99M | 16.11M | 15.92M |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative. (G): the company's own guidance — a (G) column is a guided period not yet reported; a G marker shows how the reported figure landed against the guided range. Non-GAAP-basis guidance (*) is shown as stated and never judged against GAAP actuals.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2009–FY2025: $17.21M in buybacks, $102.38M in dividends.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Peer median 3.05×
EV/EBIT
—
Peer median 31.00×
P/E (TTM)
28.62×
Peer median 31.76×
Peer medians compare against the 28 similar-size Medical Instruments & Supplies companies (of 48 listed).
Valuation over time computed as of each quarter's filing date
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Geography (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| United States | $141,566,000 | $128,743,000 | $117,811,000 | $99,463,000 | $93,866,000 | $75,222,000 | $63,130,000 | $59,078,000 |
| Other Countries | $61,672,000 | $52,071,000 | $42,906,000 | — | — | — | — | — |
| Germany | $17,897,000 | $14,420,000 | $13,420,000 | $11,223,000 | $12,968,000 | $12,365,000 | $12,400,000 | $12,445,000 |
| Canada | $15,251,000 | $13,669,000 | $10,786,000 | $8,336,000 | $7,054,000 | $5,408,000 | — | — |
| United Kingdom | $13,216,000 | $10,960,000 | $8,561,000 | $5,841,000 | $5,046,000 | — | — | — |
| Other Countries | — | $52,071,000 | $42,906,000 | $36,788,000 | $35,490,000 | $36,371,000 | $41,702,000 | $34,045,000 |
| Americas | — | $144,583,000 | $130,308,000 | — | — | — | — | — |
| Asia Pacific | — | $15,311,000 | $12,077,000 | — | — | — | — | — |
| EMEA | — | $59,969,000 | $51,099,000 | — | — | — | — | — |
Key facts
CIK
1158895
CUSIP
525558201
13F (30d)
283 filings
275 filers
Visit website
Investor relations